Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

8 Apr 2010 07:00

RNS Number : 8639J
Intercede Group PLC
08 April 2010
 



8 April 2010

Intercede Group plc

("Intercede")

 

Trading Update for the Full Year to 31 March 2010

 

We are pleased to report that Intercede is continuing to experience growth in sales revenues, pre-exceptional operating profit and cash.

 

Revenues for the year ended 31 March 2010 are expected to be approximately 10% ahead of the previous year's reported revenues of £5.7m. This is a strong performance in a difficult economic market. However, with sales slightly below expectations and having maintained our planned investment for the growth of the business, the pre-exceptional operating profit for the year (2009: £1.9m) will be ahead of last year but lower than market expectations.

 

Cash balances at 31 March 2010 total £4.7m which compares to £3.7m at 31 March 2009.

 

As previously announced, the US and UK patent litigations involving ActivIdentity were settled on 23 March 2010. The exceptional charge to the current financial year for all of the legal fees and associated costs relating to this case is expected to be in the region of £1.5m. No further legal costs are expected to arise and, as previously advised, it is not anticipated that the patent license agreement included within the settlement will have a material impact on Intercede's current or future earnings.

 

Intercede Chairman and Chief Executive Richard Parris said:

 

 "I am pleased to report an improved trading performance against a backdrop of the increasing adoption of our technology by national governments, managed service providers and large enterprise customers. Our increasing market penetration has not only provided financial returns in the current period but is also creating annuity revenue streams for the future."

 

Intercede expects to announce its full year results for the year ended 31 March 2010 by mid June 2010.

 

About Intercede

 

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

 

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

 

For more information visit http://www.intercede.com

 

ENQUIRIES

Intercede Group plc

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Tel. +44 (0)1455 558111

FinnCap

Clive Carver- Corporate Finance

Joanna Weaving - Corporate Broking

Tel. +44 (0)20 7600 1658

Pelham Bell Pottinger

Archie Berens / Francesca Tuckett

Tel. +44 (0)20 7337 1509

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWEFWFSSELL
Date   Source Headline
15th Mar 20121:02 pmRNSIssue of Equity
17th Feb 20127:00 amRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSTrading Update
12th Dec 20117:00 amRNSUS Expansion
7th Dec 201112:00 pmRNSSales Alliance
1st Dec 20117:00 amRNSInterim Results
14th Nov 20117:00 amRNSNew Partnership
4th Oct 20117:00 amRNSNew Contract Win
21st Sep 20112:55 pmRNSResult of AGM
21st Sep 20117:00 amRNSAGM Statement and Update
17th Aug 20117:00 amRNSDirector/PDMR Share Option Awards
4th Aug 20113:39 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSTrading Update
18th Jan 20119:32 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTransaction in Own Shares
30th Nov 201011:02 amRNSAdditional Listing and Director dealing
29th Nov 20107:00 amRNSIntercede Group Interim Results
4th Nov 20107:00 amRNSReduction of Share Capital
7th Oct 20107:54 amRNSPositive Trading Update
30th Sep 20107:00 amRNSNew Contract Win
24th Sep 20102:00 pmRNSResult of AGM
22nd Sep 20107:00 amRNSNew Contract Win
7th Sep 20107:00 amRNSPositive Trading Update
15th Jul 20107:00 amRNSLaunch of latest version of MyID PIV
6th Jul 20103:48 pmRNSChange of name of adviser
10th Jun 20107:00 amRNSFinal Results
8th Apr 20107:00 amRNSTrading Update
25th Mar 201012:30 pmRNSSettlement of Patent Dispute
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
1st Mar 20102:00 pmRNSMajor Subcontract with Thales
1st Feb 20107:00 amRNSNew Aerospace and Defence Contract Win
18th Jan 20104:36 pmRNSDirector/PDMR Shareholding
8th Dec 20097:00 amRNSInterim Results
11th Nov 20097:00 amRNSNew Middle East Contract Win
26th Oct 20097:00 amRNSRelease of latest Version of MyID / New Customers
12th Oct 20097:00 amRNSNational Identity Project in Kuwait
7th Oct 20097:00 amRNSTrading Update
17th Sep 20093:57 pmRNSResult of AGM
29th Jun 20095:11 pmRNSTotal Voting Rights
10th Jun 20097:00 amRNSFinal Results
8th Jun 20095:28 pmRNSDirector/PDMR Shareholding
1st Jun 20097:00 amRNSConversion of Loan Notes
14th May 20097:00 amRNSNew Contract with European Bank
30th Apr 20097:00 amRNSNew European Government Contract
2nd Apr 20097:00 amRNSTrading Update
1st Apr 20097:00 amRNSChange of Adviser
31st Mar 20097:00 amRNSTotal Voting Rights
30th Mar 20097:00 amRNSMaritime Credentialing Program Update
10th Mar 200910:21 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.